🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Isoinertial Training in Patients With COPD

RecruitingNAAges 50 Years - 80 YearsAllUniversidad Manuela Beltrán
NCT07605117 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Isoinertial training is emerging as a potentially effective strategy to improve strength and functionality in older people diagnosed with chronic obstructive pulmonary disease (COPD), due to its influence on muscle mass and neuromuscular efficiency. COPD is characterized by systemic alterations, including peripheral muscle dysfunction; which contributes to patient functional limitation, and reduces patients' quality of life. Isoinertial training may improve the physiological response to effort, and also promote functional performance in this population. Hence, the aim of this study is to evaluate the effect of an isoinertial training program on muscle strength and functional capacity in patients with COPD during an 8-week intervention.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * People between 50 - 80 years of age diagnosed with moderate or severe COPD * No acute exacerbations in the last 4 weeks * Sufficient functional capacity to exercise * Signed informed consent Exclusion Criteria: * Presence of neurological, musculoskeletal, or cardiovascular diseases that significantly limit exercise performance or compromise participant safety; including uncontrolled hypertension, recent myocardial infarction, unstable angina, severe osteoarthritis, stroke sequelae, or Parkinson's disease. * Contraindications to exercise participation according to medical evaluation. * Recent surgeries in the past 3 months * Simultaneous participation in other exercise programs * Cognitive disorders
💊

What it tests

  • Isoinertial training
  • Traditional rehabilitation (control group)
📍

Where

2 sites
Universidad Manuela Beltrán
Bogotá, Colombia
Pulsar Unidad de Neumologia y Rehabilitación Pulmonar
Ibague, Colombia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy